Number of resources: 15
Mutation Analysis of Mycobacterial rpoB Genes and Rifampin Resistance Using Recombinant Mycobacterium smegmatis. Antimicrob Agents Chemother. 2012;56(4):2008-13. Abstract
Real-Time PCR and High-Resolution Melt Analysis for Rapid Detection of Mycobacterium leprae Drug Resistance Mutations and Strain Types. J Clin Microbiol. 2012;50(3):742-53. Abstract
Mutation Analysis of Mycobacterial rpoB Genes and Rifampicin Resistance Using Recombinant Mycobacterium smegmatis. Antimicrob Agents Chemother. 2012. Abstract
A Lipopeptide Facilitate Induction of Mycobacterium leprae Killing in Host Cells. PLoS Negl Trop Dis. 2011;5(11):e1401. Abstract
FTA Card Utility for PCR Detection of Mycobacterium leprae. Jpn J Infect Dis. 2011;64(3):246-8. Abstract
Analysis of drug-resistant strains of mycobacterium leprae in an endemic area of Vietnam. Clin Infect Dis. 2011;52(5):e127-32. Abstract
Mutative analysis of the Mycobacterium leprae folP1 gene and dapsone resistance. Antimicrobial agents and chemotherapy. 2010. Abstract
Detection of serum antibodies to M. leprae major membrane protein-II in leprosy patients from Indonesia. Lepr Rev. 2009;80(4):402-9. Abstract
GM-CSF-mediated T-cell activation by macrophages infected with recombinant BCG that secretes major membrane protein-II of Mycobacterium leprae. FEMS Immunol Med Microbiol. 2009;55(1):39-46. Abstract
Serological diagnosis of leprosy in patients in vietnam by enzyme-linked immunosorbent assay with Mycobacterium leprae-derived major membrane protein II. Clin Vaccine Immunol. 2008;15(12):1755-9. Abstract
Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy. FEMS Microbiol Lett. 2007;272(2):202-5. Abstract
[Current advances in leprosy research activities]. Nihon Hansenbyo Gakkai Zasshi. 2005;74(1):3-22. Abstract
[Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene]. Nihon Hansenbyo Gakkai Zasshi. 2004;73(3):221-6. Abstract
Active surveillance of leprosy contacts in country with low prevalence rate. Int J Lepr Other Mycobact Dis. 2004;72(1):50-3. Abstract
